Institute for Biomedical Research and Innovation, National Research Council of Italy, Palermo, Italy,
Respiratory Unit, ULSS 7 Pedemontana, Bassano del Grappa, Italy.
Respiration. 2020;99(8):690-694. doi: 10.1159/000510825. Epub 2020 Aug 27.
The attenuation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, at least in Italy, allows a gradual resumption of diagnostic and therapeutic activities for sleep respiratory disorders. The knowledge on this new disorder is growing fast, but our experience is still limited and when a physician cannot rely on evidence-based medicine, the experience of his peers can support the decision-making and operational process of reopening sleep laboratories. The aim of this paper is to focus on the safety of patients and operators accessing hospitals and the practice of diagnosing and treating sleep-related respiratory disorders. The whole process requires a careful plan, starting with a triage preceding the access to the facility, to minimize the risk of infection. Preparation of the medical record can be performed through standard questionnaires administered over the phone or by e-mail, including an assessment of the COVID-19 risk. The home sleep test should include single-patient sensors or easy-to-sanitize material. The use of nasal cannulas is discouraged in view of the risk of the virus colonizing the internal reading chamber, since no filter has been tested and certified to be used extensively for coronavirus due to its small size. The adaptation to positive airway pressure (PAP) treatment can also be performed mainly using telemedicine procedures. In the adaptation session, the mask should be new or correctly sanitized and the PAP device, without a humidifier, should be protected by an antibacterial/antiviral filter, then sanitized and reassigned after at least 4 days since SARS-CoV-2 was detected on some surfaces up to 72 h after. Identification of pressure should preferably be performed by telemedicine. The patient should be informed of the risk of spreading the disease in the family environment through droplets and how to reduce this risk. The follow-up phase can again be performed mainly by telemedicine both for problem solving and the collection of data. Public access to hospital should be minimized and granted to patients only. Constant monitoring of institutional communications will help in implementing the necessary recommendations.
严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 大流行的衰减,至少在意大利,允许逐步恢复睡眠呼吸障碍的诊断和治疗活动。关于这种新疾病的知识正在迅速增加,但我们的经验仍然有限,当医生不能依赖循证医学时,他的同行的经验可以支持重新开放睡眠实验室的决策和操作过程。本文的目的是关注患者和操作人员进入医院的安全性以及诊断和治疗与睡眠相关的呼吸障碍的实践。整个过程需要精心策划,从进入医院前的分诊开始,以最大程度地降低感染风险。病历的准备可以通过标准问卷在电话或电子邮件上进行,包括对 COVID-19 风险的评估。家庭睡眠测试应包括单人传感器或易于消毒的材料。不鼓励使用鼻插管,因为病毒有在内部读取室定殖的风险,因为由于其尺寸小,尚未对用于冠状病毒的过滤器进行测试和认证。经鼻持续气道正压通气 (PAP) 治疗的适应也主要可以通过远程医疗程序进行。在适应阶段,面罩应为新的或正确消毒的,PAP 设备不应带有加湿器,应配备抗菌/抗病毒过滤器保护,然后在 SARS-CoV-2 在某些表面上检测到后至少 4 天,或在检测到后 72 小时后进行消毒和重新分配。压力的识别最好通过远程医疗进行。应告知患者疾病在家庭环境中通过飞沫传播的风险以及如何降低这种风险。随访阶段也可以主要通过远程医疗进行,无论是用于解决问题还是收集数据。应尽量减少患者进入医院的机会,并仅向患者开放。对机构通讯的持续监测将有助于实施必要的建议。